K, N., L, Z., Y, Z., Z, G., J, H., Y, P., . . . M, Z. Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationK, Nan, Zhang L, Zou Y, Geng Z, Huang J, Peng Y, Yin S, and Zhang M. Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer. Dove Medical Press.
MLA (9th ed.) CitationK, Nan, et al. Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer. Dove Medical Press.
Warning: These citations may not always be 100% accurate.